Learning Objectives

At the end of the session, participants will be able to:

• Explain the reason for the current confusion about HT benefits, risks particularly CVD and breast cancer;
• Describe current indications for HT;
• Counsel women about benefits and risks of HT.

Faculty

• John Collins, MD, Mahone Bay, NS
• Robert Reid, MD, Kingston, ON

Unrestricted Educational Grants

• Pfizer Canada

Learning Objectives

At the end of the session, participants will be able to:

• Describe the pre/peri menopausal women - health concerns, preparing her for menopause and after;
• Describe the post menopausal women and key health concerns, including osteoporosis;
• Proactive care of women 60+ - “Is 60 the new 40”;

Faculty

• Michel Fortier, MD (Moderator), Quebec, QC
• Jennifer Blake, MD, Toronto, ON
• Steven Goldstein, MD, New York, NY
• Marla Shapiro, MD, Toronto, ON

Unrestricted Educational Grants

• Amgen Canada

Best Practice Sessions A (BPS)

Learning Objectives

At the end of the session, participants will be able to:

• Understand the mechanism of action and management of common laparoscopic complications;
• Explain electrosurgical circuits in operative laparoscopy;
• Apply the above knowledge to the performance of safe laparoscopic surgery.

Faculty

• Douglas Bell, MD, Ottawa, ON
• Paul Martyn, MD, Calgary, AB

Learning Objectives

At the end of the session, participants will be able to:

• Identify the different non-malignant tumors of the vulva;
• Know the differential diagnosis of non-malignant tumors of the vulva;
• Review the indication for biopsy;
• Use the appropriate treatment.

Faculty

• Celine Bouchard, MD, Quebec, QC

Learning Objectives

At the end of the session, participants will be able to:

• Review the impact of common infectious diseases on women's health;
• Review the investigations and management of common infectious diseases in Canada.

Faculty

• Mark Yudin, MD,MSc,FRCSC, Toronto, ON

Learning Objectives

At the end of the session, participants will be able to:

• Describe all available new and older medical therapies for endometriosis;
• Upon completion the participant will have an algorithm for the conservative surgical management of endometriosis associated pain and infertility.

Faculty

• Nicholas Leyland, MD, Ancaster, ON

Learning Objectives

At the end of the session, participants will be able to:

• Understand the advantages and disadvantages of various types of laparoscopic hysterectomy especially supracervical vs. total hysterectomy;
• Understand the effects of supracervical hysterectomy to sexual function and pelvic floor;
• Describe the techniques of laparoscopic supracervical and total hysterectomy;
• Appraise the importance of patient-counseling before scheduling laparoscopic hysterectomy.

Faculty

• Togas Tulandi, MD, Montreal, QC

Learning Objectives

At the end of the session, participants will be able to:

• Ensure that you are familiar with various contraceptive options including indications, contra-indications and efficacy;
• Effectively troubleshoot common challenges associated with contraceptive use;
• Choose the most appropriate contraceptive options for patients with various medical conditions;
• Discuss recent findings in the contraceptive literature;
• Discuss current patient and/or social issues & concerns.

Faculty

• Edith Guilbert, MD, Sainte Foy, QC

Learning Objectives

At the end of the session, participants will be able to:

• To familiarize clinicians with the challenges of caring for overweight and obese parturients through the use of a frequently occurring clinical scenario;
• To identify specific risks and complications relative to each trimester and the intrapartum period using recent research findings and the newly available obesity objectives provided on the SOGC website;
• To provide concrete insight and information on ways of providing optimal care to these patients to ensure successful pregnancy outcomes.

Faculty

• Andree Gruslin, MD, Ottawa, ON
• Karen Ann Lee Visser, MD, Orleans, ON

Faculty

• Bev Young, MD, Toronto, ON

Learning Objectives

At the end of the session, participants will be able to:

• Describe the present uses of umbilical cord blood stem cells as a replacement for bone marrow transplants;
• Explain the benefits of in vitro expansion of hematopoietic stem cells;
• List the potential future uses of cord blood stem cells for tissue therapeutics.

Faculty

• Robert Casper, MD, Toronto, ON

Learning Objectives

At the end of the session, participants will be able to:

• Review the latest evidence for use of cervical cerclage;
• Discuss the indications for each method of cerclage;
• Describe the technique of cerclage.

Faculty

• Lawrence Oppenheimer, MD, Ottawa, ON

Learning Objectives

At the end of the session, participants will be able to:

• Understand the impact and burden of osteoporosis on the post menopausal woman;
• Comprehend the new classification of bone densities and the 10 year fracture risk;
• Understand which women to treat in order to reduce fractures;
• Be able to chose between the different treatment modalities;
• Learn about the new mode of action of biologic agents;
• Review the latest data on osteoporosis treatment.

Faculty

• Robert Sabbah, MD, Montreal, QC

Learning Objectives

At the end of the session, participants will be able to:

• Identify the rationale for using a standardized system for evaluating the malignant potential of an adnexal mass
• Describe the use of the Risk of Malignancy Index (RMI) in evaluating the malignant potential of an adnexal mass.

Faculty

• Jason Dodge, MD, Toronto, ON

Learning Objectives

At the end of the session, participants will be able to:

• Discuss rationale for new OC formulation and regiments;
• Describe contraception and non-contraception benefit for these new regiments;
• Counsel women about benefits and risks of new regiments.

Faculty

• Corinne Leclercq, MD (Moderator), Victoriaville, QC
• Robert Reid, MD, Kingston, ON

Unrestricted Educational Grants

• Bayer Inc.

Learning Objectives

At the end of the session, participants will be able to:

• Review the most relevant psychosexual consequences for the woman and the couple;
• Focus on often neglected issues such as “high risk partner”, anal sex risks, placebo effect of over-worrying communication on the woman and the couple);
• Empower gynecologists in dealing with this sensitive issue;
• Learn about information, motivation, and behavioral skills factors that influence physician offering, and patient uptake, of preventive HPV vaccination;
• Review scripts for initiating and discussing HPV vaccination with patients;
• Respond to cases concerning physician offering and patient response concerning HPV vaccination;
• Review Canadian data concerning psychosexual burden of HPV infection, Canadian data concerning uptake of free school based vaccination programs, and review of resistance to HPV vaccination programs from various Canadian perspectives;
• Become familiar with new Canadian research concerning the psychosocial personal emotional and quality of life burden of abnormal Pap results and genital warts.

Faculty

• Gerald Stanimir, MD (Moderator), Mont-Royal, QC
• William Fisher, BA, MS, PhD, London, ON
• Alessandra Graziottin, MD, Milan, Italy

Unrestricted Educational Grants

• Merck Canada